This federal contract award, ID SPE2DB20D3103|SPE2DB25FM0C1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENVARSUS XR 4 MG TABLET 100S. The contract is a Delivery Order with a Firm Fixed Price of $1,671.16 and an ultimate completion date of January 7, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This award is part of AmerisourceBergen's broader portfolio of federal contracts to supply essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other medical supplies, to various government agencies and military healthcare programs.
Generated 3/14/25, 10:02 AM